Chiara Ambrogio
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Melanoma and MAPK Pathways
Most-Cited Works
- → The anaplastic lymphoma kinase in the pathogenesis of cancer(2007)870 cited
- → KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS(2018)281 cited
- → Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy(2024)280 cited
- → Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology(2014)210 cited
- → Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma(2016)180 cited
- → A Braf kinase-inactive mutant induces lung adenocarcinoma(2017)150 cited
- → Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C(2017)136 cited
- → Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas(2005)128 cited
- → MT1-MMP Is Required for Myeloid Cell Fusion via Regulation of Rac1 Signaling(2010)125 cited
- → Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer(2018)125 cited